Trial: 201606014

A Phase I/II Study of Pembrolizumab (MK-3475) in Children with Advanced Melanoma or a PD-L1 Positive Advanced, Relapsed or Refractory Solid Tumor or Lymphoma (KEYNOTE-051)

Phase

I/II

Principal Investigator

Hayashi, Robert

Disease Site

Bones and Joints; Brain and Nervous System; Eye and Orbit; Hodgkin Lymphoma; Ill-Defined Sites; Kidney; Liver; Melanoma, Skin; Non-Hodgkin Lymphoma; Other Digestive Organ; Other Endocrine System; Other Female Genital; Other Male Genital; Other Skin; Soft Tissue; Thyroid; Unknown Sites

Learn more about this study at: clinicaltrials.gov